Article Information
History
- December 15, 2023.
Article Versions
- Version 1 (December 5, 2023 - 10:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fabian Kockelmann, MD1,†,
- Daniel Göhler, Dipl.-Ing.2,3,
- Sarah Barbey4,
- Amayu Wakoya Gena, M. Arch5,
- Hayder Alsaad, Dr.-Ing.5,
- Conrad Voelker, Prof, Dr.-Ing.5,
- Jürgen Zieren, Prof, MD1,
- Mehdi Ouaissi, Prof. MD, PhD6,7 and
- Urs Giger-Pabst, Prof, MD6,8
- 1Department of Surgery, Klinikum Dortmund, Hospital of the Witten/Herdecke University, Germany
- 2Topas GmbH, Dresden, Germany
- 3Research Group Mechanical Process Engineering, Institute of Process Engineering and Environmental Technology, Technische Universität Dresden, Dresden, Germany
- 4Plateforme Pixanim, INRAE PRC, 37380, Nouzilly, France
- 5Department of Building Physics, Bauhaus-University Weimar, Weimar, Germany
- 6EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, France
- 7Department of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, University Hospital of Tours, France
- 8Fliedner Fachhochschule, University of Applied Sciences, Düsseldorf, Germany
- ↵†Correspondence: Fabian Kockelmann, MD, Department of Surgery, Klinikum Dortmund, Hospital of the Witten/Herdecke University, Germany, Tel: +49 0231 953-21430, Fax: +49 0231 953-21108, Email: fabian.kockelmann{at}uni-wh.de
Posted December 15, 2023.
Chemical/technical risk analysis of a new multi-directional nebulizer (MDN) and its clinical implementation for the safe administration of Pressurized Intraperitoneal Aerosol Chemotherapy (MDN-PIPAC)
